Holen Sie sich die Stockscreener-App
1.56
5.41%
0.08
Handel nachbörslich:
1.56
Schlusskurs vom Vortag:
$1.48
Offen:
$1.52
24-Stunden-Volumen:
124.08K
Relative Volume:
0.47
Marktkapitalisierung:
$7.94M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.13M
KGV:
-0.3257
EPS:
-4.79
Netto-Cashflow:
$-16.95M
1W Leistung:
+73.33%
1M Leistung:
+51.46%
6M Leistung:
+160.00%
1J Leistung:
+906.45%
1-Tages-Spanne:
$1.33
$1.5799
1-Wochen-Bereich:
$0.84
$1.85
52-Wochen-Spanne:
$0.09
$4.49
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Firmenname
Matinas Biopharma Holdings Inc
Sektor
Branche
Telefon
908-443-1860
Adresse
1545 Route 206 South, Suite 302, Bedminster, NJ
Vergleichen Sie MTNB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
1.56 | 7.53M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2020-01-09 | Eingeleitet | Aegis Capital | Buy |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
Matinas BioPharma Holdings Inc. Shows Early Signs of Technical Strength [2025 Risk Factors]Accurate Entry/Exit Alerts - 선데이타임즈
Will breakout in Matinas BioPharma Holdings Inc. lead to full recoveryQuarterly Portfolio Review & Expert Curated Trade Setup Alerts - Newser
Should you wait for a breakout in COSCIENS Biopharma Inc.CEO Change & Low Risk High Win Rate Picks - Newser
How to interpret RSI for SMMT stock2025 Momentum Check & Daily Price Action Insights - Newser
Can technical indicators confirm Matinas BioPharma Holdings Inc.’s reversalWeekly Volume Report & Entry and Exit Point Strategies - Newser
Matinas BioPharma Holdings Inc. recovery potential after sell offJuly 2025 Review & Comprehensive Market Scan Reports - Newser
Has Matinas BioPharma Holdings Inc. found a price floorPortfolio Risk Summary & Short-Term Swing Trade Alerts - Newser
What candlestick patterns are forming on Matinas BioPharma Holdings Inc.Value Holding Return Summary With Outlook - Newser
Matinas Biopharma Holdings Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com
Can Matinas BioPharma Holdings Inc. reach all time highs this yearMulti-Fold Return Candidates - newsyoung.net
Price Channel Expanding on Matinas BioPharma Holdings Inc.’s ChartROI Boosting Trade Opportunity Calendar Published - beatles.ru
Will Matinas BioPharma Holdings Inc. bounce back from current supportEarnings Report Summary with Market Impact - Newser
Published on: 2025-08-11 01:10:21 - Newser
Detecting price anomalies in Bank of the James Financial Group Inc. with AIFree Weekly Top Gainers Forecast Watchlist - Newser
Can volume confirm reversal in Matinas BioPharma Holdings Inc.Equity Forecast with Predictive AI Screener - Newser
Is this a good reentry point in Matinas BioPharma Holdings Inc.Market Opportunity Tracker for Swing Traders - Newser
When is the best time to buy Toppoint Holdings Inc. stock3-Year Equity Summary With Setup Insights - Newser
Key resistance and support levels for Matinas BioPharma Holdings Inc.Asset Allocation Summary With Future Outlook - Newser
Matinas BioPharma Doubles Authorized Common Shares To 500M Following Shareholder Approval - 富途牛牛
What institutional flow reveals about Matinas BioPharma Holdings Inc.Low Drawdown Picks with Weekly Updates - Newser
How to read the order book for Matinas BioPharma Holdings Inc.Market Sentiment Tracker with Smart Alerts - Newser
How to build a custom watchlist for GT Biopharma Inc.Deep Learning Stock Forecast for Investors - Newser
Why Matinas BioPharma Holdings Inc. stock attracts strong analyst attentionTechnical Chart Summary for Momentum Stocks - Newser
How many analysts rate Matinas BioPharma Holdings Inc. as a “Buy”Discover high-growth stocks for your portfolio - Jammu Links News
What makes Matinas BioPharma Holdings Inc. stock price move sharplyFree Real-Time Market Sentiment Tracking Tool - Newser
Matinas BioPharma Holdings Inc. Stock Support and Resistance Levels You Should KnowFree Weekly Hot Picks With Buy Confidence - Newser
Should I hold or sell Matinas BioPharma Holdings Inc. stock in 2025Achieve exceptional returns with expert guidance - Jammu Links News
How strong is Matinas BioPharma Holdings Inc. company’s balance sheetMaximize returns with effective portfolio management - Jammu Links News
What institutional investors are buying Matinas BioPharma Holdings Inc. stockFree Expert Stock Watchlist - Jammu Links News
When is Matinas BioPharma Holdings Inc. stock expected to show significant growthUnlock exclusive trading strategies - Jammu Links News
How does Matinas BioPharma Holdings Inc. compare to its industry peersStrongest growth potential - Jammu Links News
How does Matinas BioPharma Holdings Inc. generate profit in a changing economySuperior investment outcomes - Jammu Links News
Is Matinas BioPharma Holdings Inc. stock overvalued or undervaluedFree Investment Timing Strategies - Jammu Links News
What is the dividend policy of Matinas BioPharma Holdings Inc. stockHigh-velocity capital appreciation - Jammu Links News
What are analysts’ price targets for Matinas BioPharma Holdings Inc. in the next 12 monthsIdentify undervalued stocks poised to rally - jammulinksnews.com
What are Matinas BioPharma Holdings Inc. company’s key revenue driversAchieve remarkable returns with smart investing - jammulinksnews.com
Is Matinas BioPharma Holdings Inc. a good long term investmentMaximize your returns with expert insights - Jammu Links News
What is the risk reward ratio of investing in Matinas BioPharma Holdings Inc. stockSwing Trade Review With Proven Results - Jammu Links News
Finanzdaten der Matinas Biopharma Holdings Inc-Aktie (MTNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):